ProShares Ultra NASDAQ Biotechnology
34 hedge funds and large institutions have $13.8M invested in ProShares Ultra NASDAQ Biotechnology in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
Holders
34
Holders Change
+7
Holders Change %
+25.93%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
5
Reduced
6
Closed
3
Calls
$5.57M
Puts
$8.24M
Net Calls
-$2.67M
Net Calls Change
+$1.19M
Top Buyers
1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$3.34M |
2 |
VF
2
Virtu Financial
New York
|
$1.59M |
3 |
HF
3
HRT Financial
New York
|
$263K |
4 |
SW
4
SlateStone Wealth
Jupiter,
Florida
|
$258K |
5 |
MC
5
Moors & Cabot
Boston,
Massachusetts
|
$207K |